Granahan Investment Management LLC Raises Stake in Alignment Healthcare, Inc. $ALHC

Granahan Investment Management LLC boosted its position in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 29.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 749,487 shares of the company’s stock after buying an additional 168,758 shares during the period. Granahan Investment Management LLC’s holdings in Alignment Healthcare were worth $14,802,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Parallel Advisors LLC boosted its position in Alignment Healthcare by 87.7% in the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after buying an additional 773 shares during the last quarter. Larson Financial Group LLC purchased a new stake in Alignment Healthcare in the third quarter valued at approximately $33,000. First Horizon Corp purchased a new stake in Alignment Healthcare in the fourth quarter valued at approximately $39,000. GAMMA Investing LLC boosted its position in Alignment Healthcare by 83.8% in the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after buying an additional 987 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new stake in Alignment Healthcare in the third quarter valued at approximately $53,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Trading Up 4.1%

Shares of ALHC stock opened at $20.60 on Wednesday. The company has a debt-to-equity ratio of 1.56, a current ratio of 1.58 and a quick ratio of 1.58. The company has a market cap of $4.26 billion, a price-to-earnings ratio of 228.89, a PEG ratio of 2.67 and a beta of 1.14. The stock has a 50 day simple moving average of $18.59 and a 200-day simple moving average of $19.43. Alignment Healthcare, Inc. has a 1-year low of $11.63 and a 1-year high of $23.87.

Alignment Healthcare (NASDAQ:ALHC) last announced its earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.04. The business had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The business’s quarterly revenue was up 33.3% on a year-over-year basis. During the same period in the prior year, the company posted ($0.05) EPS. On average, equities research analysts expect that Alignment Healthcare, Inc. will post 0.2 EPS for the current fiscal year.

Insider Transactions at Alignment Healthcare

In other news, President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $16.09, for a total transaction of $482,700.00. Following the completion of the transaction, the president directly owned 998,813 shares of the company’s stock, valued at $16,070,901.17. This represents a 2.92% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Hyong Kim sold 35,951 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $19.86, for a total value of $713,986.86. Following the transaction, the insider directly owned 331,750 shares of the company’s stock, valued at approximately $6,588,555. The trade was a 9.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,428,666 shares of company stock valued at $27,752,485 in the last three months. 5.20% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. UBS Group upped their target price on Alignment Healthcare from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Friday, May 1st. Barclays decreased their price target on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a report on Tuesday, May 26th. Raymond James Financial set a $22.00 price target on Alignment Healthcare in a report on Thursday, May 7th. Zacks Research raised Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a report on Tuesday, April 28th. Finally, Weiss Ratings raised Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a report on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Alignment Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $24.30.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.